Holen Sie sich die Stockscreener-App
0.2218
3.57%
-0.0082
Sunshine Biopharma Inc Aktie (SBFM) Neueste Nachrichten
Sunshine Biopharma Closes $6 Million Equity Offering - marketscreener.com
Sunshine Biopharma Completes $6 Million Public Offering - The Globe and Mail
Form 4 Sunshine Biopharma Inc For: 9 October By Investing.com - Investing.com Nigeria
Sunshine Biopharma Taps Aegis for $6 Million Public Offering of Units and Warrants - TradingView
Sunshine Biopharma, Inc. (SBFM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Sunshine Biopharma Announces Closing of up to $20.4 Million Public Offering - ACCESS Newswire
Sunshine Biopharma Inc. (SBFM) Closes ~$6.0M Offering; Up to $14.4M via Warrants - TradingView
Sunshine Biopharma Inc. (SBFM) Closes $6.0M Offering; Up To $14.4M More If Warrants Exercise - TradingView
Sunshine Biopharma Prices $6 Million Public Offering at $0.55 Per Unit, Raising Dilution Concerns - Yahoo Finance
Sunshine Biopharma (SBFM) Announces $6M Public Offering at $0.55 per Unit - GuruFocus
Sunshine Biopharma (SBFM) Prices $6M Public Offering with Warran - GuruFocus
Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering - Weatherford Democrat
Sunshine Biopharma Inc. (SBFM) Prices ~$6.0M Offering - TradingView
SBFM Stock Pops As Sunshine Biopharma Pushes Antiviral, Generics - Timothy Sykes
SBFM Stock Attracts Traders As Antiviral And Generics Story Builds - StocksToTrade
Sunshine Biopharma Inc. SEC Filing (Oct 8, 2026) - Stock Titan
Sunshine Biopharma Soars as Traders Appear to Chase a Speculative Rebound - Moomoo
Sunshine Biopharma Soars as Traders Appear to Chase a Speculative Rebound - Quiver Quantitative
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Warrants for 200,000 shares feature in Alta’s amended Sunshine Biopharma (SBFM) stake report. - Stock Titan
Shares traded below Nasdaq’s $1 minimum. Sunshine Biopharma (SBFM) has approved a possible reverse split. - Stock Titan
Sunshine Biopharma, Inc. (SBFM) Upgraded to Buy: Here's What You Should Know - finance.yahoo.com
Sunshine Biopharma launches generic ondansetron in Canada - Investing.com
Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio - Corsicana Daily Sun
Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio - Times Argus
A generic drug for nausea during cancer treatment launches in Canada - Stock Titan
Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio - FinancialContent
Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio - Yahoo Finance
Sunshine Biopharma Stock (SUNB) Opinions on Coronavirus Drug Studies - Quiver Quantitative
Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies - Yahoo Finance
An oral drug candidate suppressed lung virus in infected mice - Stock Titan
EXCLUSIVE: Sunshine Biopharma Advances 'Differentiated Antiviral Candidate' to IND-Enabling Studies - Yahoo Finance
Sunshine Biopharma Inc. (NASDAQ:SBFM) Advances Lead COVID Antiviral to IND-Enabling Studies - TradingView
Form 8K Sunshine Biopharma Inc For: 11 September By Investing.com - Investing.com South Africa
Sunshine Biopharma reduces Series B warrant exercise price to $1.2046 By Investing.com - Investing.com South Africa
Sunshine Biopharma reduces Series B warrant exercise price to $1.2046 - Investing.com
Sunshine Biopharma reduces Series B warrant exercise price to $1.2046 By Investing.com - Investing.com India
Form 8K Sunshine Biopharma Inc For: 11 September By Investing.com - Investing.com Canada
Form 8K Sunshine Biopharma Inc For: 11 September By Investing.com - Investing.com UK
Sunshine Biopharma cuts warrant exercise price to 1.2 - Bitget
Sunshine Biopharma (NASDAQ: SBFM) Anticipates $31M from Series B Warrant Exercises - kalkinemedia.com
Price to earnings forward of Sunshine Biopharma Inc. – BOATS:SBFMW - TradingView
Price to sales forward of Sunshine Biopharma Inc. – BOATS:SBFMW - TradingView
Sunshine Biopharma Inc. SEC Filing (Sep 9, 2026) - Stock Titan
Sunshine Biopharma receives Canadian approval for atenolol tablets By Investing.com - Investing.com Nigeria
Sunshine Biopharma Announces Board Vacancy as Dr. Andrew Keller Steps Down After Term Ends - kalkinemedia.com
SBFM Looks 52.9% Undervalued on GF Value™ Despite Weak Fundamentals - GuruFocus
Sunshine Biopharma receives Canadian approval for atenolol tablets By Investing.com - Investing.com India
Sunshine Biopharma receives Canadian approval for atenolol tablets By Investing.com - Investing.com UK
Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions - Cadillac News
4.51%
5.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):